Cite
Comparing the effectiveness and costs of Bevacizumab to Ranibizumab in patients with Diabetic Macular Edema: a randomized clinical trial (the BRDME study)
MLA
Schauwvlieghe, A. M., et al. “Comparing the Effectiveness and Costs of Bevacizumab to Ranibizumab in Patients with Diabetic Macular Edema: A Randomized Clinical Trial (the BRDME Study).” BMC Ophthalmology, 2015. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1284099922&authtype=sso&custid=ns315887.
APA
Schauwvlieghe, A. M., Dijkman, G., Hooymans, J. M., Verbraak, F. D., Hoyng, C. B., Dijkgraaf, M. G., Leeuwen, R. V., Vingerling, J. R., Moll, A. C., & Schlingemann, R. O. (2015). Comparing the effectiveness and costs of Bevacizumab to Ranibizumab in patients with Diabetic Macular Edema: a randomized clinical trial (the BRDME study). BMC Ophthalmology.
Chicago
Schauwvlieghe, A.M., G. Dijkman, J.M. Hooymans, F.D. Verbraak, C.B. Hoyng, M.G. Dijkgraaf, R. Van Leeuwen, J.R. Vingerling, A.C. Moll, and R.O. Schlingemann. 2015. “Comparing the Effectiveness and Costs of Bevacizumab to Ranibizumab in Patients with Diabetic Macular Edema: A Randomized Clinical Trial (the BRDME Study).” BMC Ophthalmology. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1284099922&authtype=sso&custid=ns315887.